BDBM694249 3-((4-bromo-1,1,2,2-tetrafluoro-3-hydroxy-3-methyl- 2,3-dihydro-1H-inden-5-yl)oxy)-5-fluorobenzonitrile::US12077506, Compound I-16

SMILES CC1(O)c2c(ccc(Oc3cc(F)cc(c3)C#N)c2Br)C(F)(F)C1(F)F

InChI Key InChIKey=WLTUSIVVZKLOHD-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 694249   

TargetVascular endothelial growth factor A(Human)
Nikang Therapeutics

US Patent
LigandPNGBDBM694249(3-((4-bromo-1,1,2,2-tetrafluoro-3-hydroxy-3-methyl...)
Affinity DataEC50:  2.07E+3nMAssay Description:The ability of the disclosed compounds to inhibit HIF-2alpha was measured by determining VEGF expression in 786-O cells. About 7500 786-O cells were ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent